PT Charlie Hospital Semarang Tbk (IDX:RSCH)
Indonesia · Delayed Price · Currency is IDR 392.00
+2.00 (0.51%)
At close: Oct 30, 2025
IDX:RSCH Revenue
PT Charlie Hospital Semarang Tbk had revenue of 15.73B IDR in the quarter ending June 30, 2025, with 30.71% growth. This brings the company's revenue in the last twelve months to 51.60B, up 9.01% year-over-year. In the year 2024, PT Charlie Hospital Semarang Tbk had annual revenue of 48.50B with 15.04% growth.
Revenue (ttm)
51.60B
Revenue Growth
+9.01%
P/S Ratio
20.13
Revenue / Employee
243.39M
Employees
214
Market Cap
1.04T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.50B | 6.34B | 15.04% |
| Dec 31, 2023 | 42.16B | 9.13B | 27.63% |
| Dec 31, 2022 | 33.03B | -2.52B | -7.10% |
| Dec 31, 2021 | 35.56B | 22.29B | 168.08% |
| Dec 31, 2020 | 13.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Tempo Scan Pacific Tbk | 13.48T |
| PT Siloam International Hospitals Tbk | 12.30T |
| PT Soho Global Health Tbk | 10.35T |
| PT Lippo Karawaci Tbk | 7.44T |
| PT Medikaloka Hermina Tbk | 6.98T |
| PT Mitra Keluarga Karyasehat Tbk | 5.24T |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3.85T |